Copyright Reports & Markets. All rights reserved.

Global Amyotrophic Lateral Sclerosis Drugs Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis Drugs Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Riluzole
    • 1.4.3 Edaravone (Radicava)
    • 1.4.4 CoQ10
    • 1.4.5 Butylphthalide
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital Pharmacies
    • 1.5.3 Retail Pharmacies
    • 1.5.4 Online Pharmacies
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Perspective (2015-2026)
  • 2.2 Global Amyotrophic Lateral Sclerosis Drugs Growth Trends by Regions
    • 2.2.1 Amyotrophic Lateral Sclerosis Drugs Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Amyotrophic Lateral Sclerosis Drugs Historic Market Share by Regions (2015-2020)
    • 2.2.3 Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Amyotrophic Lateral Sclerosis Drugs Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Amyotrophic Lateral Sclerosis Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Amyotrophic Lateral Sclerosis Drugs Players by Market Size
    • 3.1.1 Global Top Amyotrophic Lateral Sclerosis Drugs Players by Revenue (2015-2020)
    • 3.1.2 Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Amyotrophic Lateral Sclerosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Amyotrophic Lateral Sclerosis Drugs Market Concentration Ratio
    • 3.2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis Drugs Revenue in 2019
  • 3.3 Amyotrophic Lateral Sclerosis Drugs Key Players Head office and Area Served
  • 3.4 Key Players Amyotrophic Lateral Sclerosis Drugs Product Solution and Service
  • 3.5 Date of Enter into Amyotrophic Lateral Sclerosis Drugs Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Amyotrophic Lateral Sclerosis Drugs Historic Market Size by Type (2015-2020)
  • 4.2 Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)
  • 5.2 Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
  • 6.2 Amyotrophic Lateral Sclerosis Drugs Key Players in North America (2019-2020)
  • 6.3 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
  • 6.4 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
  • 7.2 Amyotrophic Lateral Sclerosis Drugs Key Players in Europe (2019-2020)
  • 7.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
  • 7.4 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)

8 China

  • 8.1 China Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
  • 8.2 Amyotrophic Lateral Sclerosis Drugs Key Players in China (2019-2020)
  • 8.3 China Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
  • 8.4 China Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
  • 9.2 Amyotrophic Lateral Sclerosis Drugs Key Players in Japan (2019-2020)
  • 9.3 Japan Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
  • 9.4 Japan Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
  • 10.2 Amyotrophic Lateral Sclerosis Drugs Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)

11 India

  • 11.1 India Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
  • 11.2 Amyotrophic Lateral Sclerosis Drugs Key Players in India (2019-2020)
  • 11.3 India Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
  • 11.4 India Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
  • 12.2 Amyotrophic Lateral Sclerosis Drugs Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
  • 12.4 Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Sanofi
    • 13.1.1 Sanofi Company Details
    • 13.1.2 Sanofi Business Overview
    • 13.1.3 Sanofi Amyotrophic Lateral Sclerosis Drugs Introduction
    • 13.1.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020))
    • 13.1.5 Sanofi Recent Development
  • 13.2 Mitsubishi Tanabe Pharma
    • 13.2.1 Mitsubishi Tanabe Pharma Company Details
    • 13.2.2 Mitsubishi Tanabe Pharma Business Overview
    • 13.2.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
    • 13.2.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
    • 13.2.5 Mitsubishi Tanabe Pharma Recent Development
  • 13.3 Mylan
    • 13.3.1 Mylan Company Details
    • 13.3.2 Mylan Business Overview
    • 13.3.3 Mylan Amyotrophic Lateral Sclerosis Drugs Introduction
    • 13.3.4 Mylan Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
    • 13.3.5 Mylan Recent Development
  • 13.4 Apotex
    • 13.4.1 Apotex Company Details
    • 13.4.2 Apotex Business Overview
    • 13.4.3 Apotex Amyotrophic Lateral Sclerosis Drugs Introduction
    • 13.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
    • 13.4.5 Apotex Recent Development
  • 13.5 Glemark Generics
    • 13.5.1 Glemark Generics Company Details
    • 13.5.2 Glemark Generics Business Overview
    • 13.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Introduction
    • 13.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
    • 13.5.5 Glemark Generics Recent Development
  • 13.6 Sun Pharma
    • 13.6.1 Sun Pharma Company Details
    • 13.6.2 Sun Pharma Business Overview
    • 13.6.3 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
    • 13.6.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
    • 13.6.5 Sun Pharma Recent Development
  • 13.7 Covis Pharma
    • 13.7.1 Covis Pharma Company Details
    • 13.7.2 Covis Pharma Business Overview
    • 13.7.3 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
    • 13.7.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
    • 13.7.5 Covis Pharma Recent Development
  • 13.8 Lunan Pharma
    • 13.8.1 Lunan Pharma Company Details
    • 13.8.2 Lunan Pharma Business Overview
    • 13.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
    • 13.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
    • 13.8.5 Lunan Pharma Recent Development
  • 13.9 CSPC Pharmaceutical
    • 13.9.1 CSPC Pharmaceutical Company Details
    • 13.9.2 CSPC Pharmaceutical Business Overview
    • 13.9.3 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Introduction
    • 13.9.4 CSPC Pharmaceutical Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
    • 13.9.5 CSPC Pharmaceutical Recent Development
  • 13.10 Ascend Laboratories
    • 13.10.1 Ascend Laboratories Company Details
    • 13.10.2 Ascend Laboratories Business Overview
    • 13.10.3 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Introduction
    • 13.10.4 Ascend Laboratories Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
    • 13.10.5 Ascend Laboratories Recent Development
  • 13.11 EISAI
    • 10.11.1 EISAI Company Details
    • 10.11.2 EISAI Business Overview
    • 10.11.3 EISAI Amyotrophic Lateral Sclerosis Drugs Introduction
    • 10.11.4 EISAI Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
    • 10.11.5 EISAI Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Amyotrophic Lateral Sclerosis Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Amyotrophic Lateral Sclerosis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Sanofi
    Mitsubishi Tanabe Pharma
    Mylan
    Apotex
    Glemark Generics
    Sun Pharma
    Covis Pharma
    Lunan Pharma
    CSPC Pharmaceutical
    Ascend Laboratories
    EISAI

    Market segment by Type, the product can be split into
    Riluzole
    Edaravone (Radicava)
    CoQ10
    Butylphthalide
    Others
    Market segment by Application, split into
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now